There are increasing data to show that low-dose combination therapy may provide us with a very attractive alternative as first-line treatment for hypertension, or at least should be used earlier ...

The β-blocker atenolol is used widely as a first-line treatment for hypertension and as a reference drug in clinical trials. Prompted by a finding that the angiotensin-receptor blocker losartan ...

Hypertension, also known as high blood pressure, is the most common cardiovascular risk factor. It describes a condition ...

The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...

Erri, S. and Oroszi, T. (2025) Isolated Systolic Hypertension in Geriatrics. International Journal of Clinical Medicine, 16, ...

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

For others, hypertension might result in hearing loss. Sounds may seem muffled, or you may not hear well at a certain volume. Treating hypertension is the first step in managing ear conditions ...